Abstract
Mannitol is effective in reducing ICP, and we recommend its use in the management of traumatic intracranial hypertension. Serum osmolalities greater than 320 mOSsm/L and hypovolemia should be avoided. Some data suggest that bolus administration is preferable to continuous infusion.
Publication types
-
Guideline
-
Practice Guideline
-
Review
MeSH terms
-
Animals
-
Brain Injuries / complications
-
Brain Injuries / physiopathology
-
Brain Injuries / therapy*
-
Craniocerebral Trauma / complications
-
Craniocerebral Trauma / physiopathology
-
Craniocerebral Trauma / therapy*
-
Diuretics, Osmotic / therapeutic use*
-
Dogs
-
Emergencies
-
Humans
-
Intracranial Pressure*
-
MEDLINE
-
Mannitol / therapeutic use*
-
Pseudotumor Cerebri / etiology
-
Pseudotumor Cerebri / prevention & control*
Substances
-
Diuretics, Osmotic
-
Mannitol